Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
126560.KS Stock Summary
In the News
126560.KS Financial details
Company Rating
Sell
Market Cap
385.54B
Income
-1.88B
Revenue
168.61B
Book val./share
6725.57
Cash/share
5091.79
Dividend
90
Dividend %
2.89%
Employees
46
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-105.23
Forward P/E
-
PEG
32.28
P/S
2.07
P/B
0.46
P/C
0.73
P/FCF
-32.12
Quick Ratio
-
Current Ratio
9.09
Debt / Equity
0.05
LT Debt / Equity
0
-
-
EPS (TTM)
-17.08
EPS next Y
-
EPS next Q
-
EPS this Y
-32.6%
EPS next Y
-
EPS next 5Y
-1909.13%
EPS last 5Y
NAN%
Revenue last 5Y
-10.45%
Revenue Q/Q
-6.68%
EPS Q/Q
-612.44%
-
-
-
-
SMA20
-3.83%
SMA50
15.78%
SMA100
9.76%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
28%
Oper. Margin
2%
Profit Margin
-2%
Payout
-21%
Shs Outstand
110.15M
Shs Float
25.33M
-
-
-
-
Target Price
-
52W Range
2530.0-3910.0
52W High
-5.24%
52W Low
+46.44%
RSI
68
Rel Volume
0.71
Avg Volume
176.17K
Volume
124.22K
Perf Week
7.86%
Perf Month
8.02%
Perf Quarter
20.29%
Perf Half Y
17.43%
-
-
-
-
Beta
0.229
-
-
Volatility
109.61%, 124.33%
Prev Close
0.14%
Price
3705
Change
0.68%
126560.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.66K | 2.8K | 1.24K | 1.4K | 1.53K | |
Net income per share | 343.14 | -366.51 | -271.37 | -25.34 | -17.08 | |
Operating cash flow per share | 746.72 | 186.41 | 741.52 | -837.4 | 86.53 | |
Free cash flow per share | 479.82 | -74.77 | 422.13 | -911.78 | -105.51 | |
Cash per share | 3.26K | 2.78K | 3.49K | 3.5K | 5.09K | |
Book value per share | 6.73K | 6.27K | 6.97K | 6.85K | 6.73K | |
Tangible book value per share | 4.61K | 4.24K | 7.1K | 7.17K | 7.22K | |
Share holders equity per share | 6.73K | 6.27K | 6.97K | 6.85K | 6.73K | |
Interest debt per share | 29.79 | 394.96 | 348.95 | 365.02 | 339.45 | |
Market cap | 375.62B | 424.64B | 464.3B | 271.38B | 352.49B | |
Enterprise value | 364.47B | 434.96B | 444.88B | 287.77B | 321.83B | |
P/E ratio | 9.94 | -10.52 | -15.53 | -97.49 | -187.39 | |
Price to sales ratio | 1.28 | 1.38 | 3.4 | 1.76 | 2.09 | |
POCF ratio | 4.57 | 20.68 | 5.68 | -2.95 | 36.98 | |
PFCF ratio | 7.11 | -51.56 | 9.99 | -2.71 | -30.33 | |
P/B Ratio | 0.51 | 0.61 | 0.6 | 0.36 | 0.48 | |
PTB ratio | 0.51 | 0.61 | 0.6 | 0.36 | 0.48 | |
EV to sales | 1.24 | 1.41 | 3.25 | 1.87 | 1.91 | |
Enterprise value over EBITDA | 3.91 | 7.33 | 15.46 | 73.92 | 21.41 | |
EV to operating cash flow | 4.43 | 21.18 | 5.45 | -3.13 | 33.76 | |
EV to free cash flow | 6.9 | -52.81 | 9.57 | -2.87 | -27.69 | |
Earnings yield | 0.1 | -0.1 | -0.06 | -0.01 | -0.01 | |
Free cash flow yield | 0.14 | -0.02 | 0.1 | -0.37 | -0.03 | |
Debt to equity | 0 | 0.06 | 0.05 | 0.05 | 0.05 | |
Debt to assets | 0 | 0.04 | 0.04 | 0.04 | 0.04 | |
Net debt to EBITDA | -0.12 | 0.17 | -0.67 | 4.21 | -2.04 | |
Current ratio | 6.43 | 3.55 | 2.66 | 7.21 | 9.67 | |
Interest coverage | 175.06 | 37.25 | -4.74 | -5.87 | 1.54 | |
Income quality | 2.18 | -0.51 | 0.96 | 33.05 | -5.07 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | |
Payout ratio | 0.17 | -0.16 | -0.33 | -3.56 | -5.27 | |
Sales general and administrative to revenue | 0.08 | 0.07 | 0.02 | 0.02 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0.06 | 0.05 | 0.04 | |
Intangibles to total assets | 0.29 | 0.32 | 0.07 | 0.06 | 0.05 | |
Capex to operating cash flow | -0.36 | -1.4 | -0.43 | 0.09 | -2.22 | |
Capex to revenue | -0.1 | -0.09 | -0.26 | -0.05 | -0.13 | |
Capex to depreciation | -0.64 | -0.76 | -0.99 | -0.69 | -1.68 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.21K | 7.19K | 6.52K | 1.98K | 1.61K | |
ROIC | 0.04 | -0.06 | -0.01 | 0.01 | 0 | |
Return on tangible assets | 0.07 | -0.06 | -0.03 | 0 | 0 | |
Graham Net | 2.94K | 1.64K | 2.25K | 3.21K | 4.77K | |
Working capital | 348.31B | 310.67B | 279.04B | 385.12B | 564.22B | |
Tangible asset value | 508.1B | 467.01B | 781.68B | 787.65B | 795.1B | |
Net current asset value | 340.45B | 223.7B | 271.12B | 376.9B | 556.29B | |
Invested capital | 0 | 0.06 | 0.05 | 0.05 | 0.05 | |
Average receivables | 52.64B | 70.31B | 62.19B | 30.25B | 25.04B | |
Average payables | 13.23B | 13.52B | 8.2B | 5.57B | 7.46B | |
Average inventory | 30.02M | 14.54B | 29.64B | 32.35B | 38.43B | |
Days sales outstanding | 61.21 | 108.44 | 87.79 | 65.37 | 48.63 | |
Days payables outstanding | 34.05 | 16.73 | 25.93 | 15.39 | 30.01 | |
Days of inventory on hand | 0 | 49.85 | 117.95 | 118.02 | 121.91 | |
Receivables turnover | 5.96 | 3.37 | 4.16 | 5.58 | 7.51 | |
Payables turnover | 10.72 | 21.82 | 14.08 | 23.72 | 12.16 | |
Inventory turnover | 462.99K | 7.32 | 3.09 | 3.09 | 2.99 | |
ROE | 0.05 | -0.06 | -0.04 | 0 | 0 | |
Capex per share | -266.9 | -261.18 | -319.38 | -74.38 | -192.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 286.89 | 359.47 | 433.71 | 381.34 | 355.85 | |
Net income per share | -144.87 | 71.26 | 18.07 | 25.81 | -132.26 | |
Operating cash flow per share | 25.23 | -10.89 | -46.28 | 135.89 | 7.84 | |
Free cash flow per share | -8.26 | -29.37 | -82.84 | 68.91 | -62.17 | |
Cash per share | 3.49K | 3.45K | 2.69K | 4.42K | 5.09K | |
Book value per share | 6.84K | 6.81K | 6.83K | 6.86K | 6.73K | |
Tangible book value per share | 7.15K | 7.13K | 7.17K | 7.22K | 7.22K | |
Share holders equity per share | 6.84K | 6.81K | 6.83K | 6.86K | 6.73K | |
Interest debt per share | 354.98 | 266.83 | 328.23 | 341.69 | 328.44 | |
Market cap | 272.08B | 345.49B | 320.14B | 339.27B | 352.49B | |
Enterprise value | 288.47B | 350.68B | 335.02B | 346.58B | 321.83B | |
P/E ratio | -4.26 | 11 | 40.18 | 29.83 | -6.05 | |
Price to sales ratio | 8.61 | 8.72 | 6.7 | 8.08 | 8.99 | |
POCF ratio | 97.89 | -287.86 | -62.77 | 22.67 | 408.37 | |
PFCF ratio | -299.01 | -106.74 | -35.07 | 44.69 | -51.48 | |
P/B Ratio | 0.36 | 0.46 | 0.43 | 0.45 | 0.48 | |
PTB ratio | 0.36 | 0.46 | 0.43 | 0.45 | 0.48 | |
EV to sales | 9.13 | 8.85 | 7.01 | 8.25 | 8.21 | |
Enterprise value over EBITDA | -14.07 | 29.76 | 27.01 | 27.5 | -526.34 | |
EV to operating cash flow | 103.79 | -292.18 | -65.69 | 23.15 | 372.84 | |
EV to free cash flow | -317.01 | -108.34 | -36.7 | 45.66 | -47 | |
Earnings yield | -0.06 | 0.02 | 0.01 | 0.01 | -0.04 | |
Free cash flow yield | 0 | -0.01 | -0.03 | 0.02 | -0.02 | |
Debt to equity | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Debt to assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Net debt to EBITDA | -0.8 | 0.44 | 1.2 | 0.58 | 50.15 | |
Current ratio | 7.21 | 6.43 | 6.51 | 9.09 | 9.67 | |
Interest coverage | -9.95 | -0.29 | 7.43 | 2.64 | -10.84 | |
Income quality | -0.17 | -0.12 | -1.1 | 2.96 | -0.06 | |
Dividend Yield | 0 | 0 | 0.03 | 0 | 0 | |
Payout ratio | -0.04 | 0 | 4.98 | 0 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.24 | 0.2 | 0.27 | 0.03 | |
Research and developement to revenue | 0.07 | 0.04 | 0.04 | 0.04 | 0.05 | |
Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | |
Capex to operating cash flow | -1.33 | 1.7 | 0.79 | -0.49 | -8.93 | |
Capex to revenue | -0.12 | -0.05 | -0.08 | -0.18 | -0.2 | |
Capex to depreciation | -1.2 | -0.68 | -1.29 | -2.31 | -2.34 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.72K | 3.3K | 1.67K | 2K | 4.47K | |
ROIC | -0.01 | 0 | 0 | 0 | -0.01 | |
Return on tangible assets | -0.02 | 0.01 | 0 | 0 | -0.02 | |
Graham Net | 3.2K | 3.14K | 2.55K | 4.16K | 4.77K | |
Working capital | 385.12B | 380.21B | 317.13B | 492.08B | 564.22B | |
Tangible asset value | 787.65B | 786.14B | 790.51B | 795.67B | 795.1B | |
Net current asset value | 376.9B | 371.82B | 309.27B | 483.94B | 556.29B | |
Invested capital | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Average receivables | 30.23B | 31.54B | 39.7B | 37.73B | 27B | |
Average payables | 4.32B | 4.81B | 4.82B | 5.28B | 8.23B | |
Average inventory | 34.04B | 34.24B | 33.98B | 34.06B | 38.25B | |
Days sales outstanding | 78.65 | 80.58 | 82.7 | 67.57 | 51.58 | |
Days payables outstanding | 17.03 | 16.57 | 11.49 | 18.47 | 29.5 | |
Days of inventory on hand | 130.62 | 109.89 | 86.42 | 104.47 | 119.83 | |
Receivables turnover | 1.14 | 1.12 | 1.09 | 1.33 | 1.74 | |
Payables turnover | 5.29 | 5.43 | 7.83 | 4.87 | 3.05 | |
Inventory turnover | 0.69 | 0.82 | 1.04 | 0.86 | 0.75 | |
ROE | -0.02 | 0.01 | 0 | 0 | -0.02 | |
Capex per share | -33.49 | -18.48 | -36.56 | -66.98 | -70 |
126560.KS Frequently Asked Questions
What is HCN Co., Ltd. stock symbol ?
HCN Co., Ltd. is a KR stock and trading under the symbol 126560.KS
What is HCN Co., Ltd. stock quote today ?
HCN Co., Ltd. stock price is $3705 today.
Is HCN Co., Ltd. stock public?
Yes, HCN Co., Ltd. is a publicly traded company.